David Bredt

Insider Reports History

Entity
Individual
Location
C/O Rapport Therapeutics, 1325 Boylston St., Suite 401, Boston, MA
Signature
/s/ Cheryl Gault, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Bredt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Scientific Officer Common Stock 478K Jun 6, 2024 Direct
Rapport Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 28.3K Jun 6, 2024 Direct

Insider Reports Filed by David Bredt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Chief Scientific Officer
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Chief Scientific Officer